Global Biological Safety Testing Market 2022 - Snapshot

September 2022 | 32 pages | ID: GBCE49300D66EN
Gen Consulting Company

Abstracts

According to market research study published by Gen Consulting Company, the market size of the global biological safety testing sector is expected to rise by USD 14 billion with a CAGR of 16.3% by the end of 2028.

This industry report offers market estimates of the global market, followed by a detailed analysis of the segmentation, technology, application, and region. The global market data on biological safety testing can be segmented by segmentation: analytical testing, in vitro testing, in vivo testing. The analytical testing segment captured the largest share of the market in 2021. Biological safety testing market is further segmented by technology: animal–based, cell–based, in vitro kits, protein (mAb), others. The mAb segment held the largest share of the global biological safety testing market in 2021 and is anticipated to hold its share during the forecast period. Based on application, the biological safety testing market is segmented into: adventitious agents, host cell contaminant testing, product release testing, pyrogen and endotoxins testing, sterility and bioburden testing. In 2021, the product release testing segment made up the largest share of revenue generated by the biological safety testing market. On the basis of region, the biological safety testing market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

The global biological safety testing market is highly competitive. The prominent players operating in the global biological safety testing market include BioReliance Corporation, Charles River Laboratories Inc., Eurofins Scientific SE, Lonza Group AG, SGS S.A., Thermo Fisher Scientific Inc., WuXi AppTec Co. Ltd.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Biological Safety Testing Market
• Identify segments/areas to invest in over the forecast period in the Global Biological Safety Testing Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. BIOLOGICAL SAFETY TESTING MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY SEGMENTATION

Analytical testing
In vitro testing
In vivo testing

PART 5. MARKET BREAKDOWN BY TECHNOLOGY

Animal–based
Cell–based
In vitro kits
Protein (mAb)
Others

PART 6. MARKET BREAKDOWN BY APPLICATION

Adventitious agents
Host cell contaminant testing
Product release testing
Pyrogen and endotoxins testing
Sterility and bioburden testing

PART 7. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 8. KEY COMPANIES

BioReliance Corporation
Charles River Laboratories, Inc.
Eurofins Scientific SE
Lonza Group AG
SGS S.A.
Thermo Fisher Scientific, Inc.
WuXi AppTec Co., Ltd.

PART 9. METHODOLOGY